Predicting response to statins by pharmacogenetic testing

Pharmacogenomics. 2012 Aug;13(11):1223-5. doi: 10.2217/pgs.12.107.

Authors

Ingrid C Gelissen¹, Andrew J Brown

Affiliation

¹ Faculty of Pharmacy, University of Sydney, Australia. ingrid.gelissen@sydney.edu.au

PMID: 22920392
DOI: 10.2217/pgs.12.107

No abstract available

MeSH terms

ATP Binding Cassette Transporter, Subfamily G, Member 2
ATP-Binding Cassette Transporters / genetics
Biomarkers, Pharmacological
Cholesterol, LDL / metabolism*
Humans
Hydroxymethylglutaryl CoA Reductases / genetics
Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage*
Liver-Specific Organic Anion Transporter 1
Neoplasm Proteins / genetics
Organic Anion Transporters / genetics
Pharmacogenetics

Substances

ABCG2 protein, human
ATP Binding Cassette Transporter, Subfamily G, Member 2
ATP-Binding Cassette Transporters
Biomarkers, Pharmacological
Cholesterol, LDL
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Liver-Specific Organic Anion Transporter 1
Neoplasm Proteins
Organic Anion Transporters
SLCO1B1 protein, human
HMGCR protein, human
Hydroxymethylglutaryl CoA Reductases